Genenta Science SPAGNTA -5.26%31 PB Ratio is 1.40 as of Jul. 08, 2026. GuruFocus rates GNTA with a GF Score™ of 31/100. The stock has 4 warning signs investors should review. Among 1,225 Biotechnology companies, Genenta Science SPA ranks better than 70.12% on this metric.
The historical rank and industry rank for Genenta Science SPA's PB Ratio or its related term are showing as below:
GNTA'
s PB Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 1.48
Current: 1.4
During the past 7 years, Genenta Science SPA's highest PB Ratio was 1.48. The lowest was 0.00. And the median was 0.00.
GNTA's PB Ratio is ranked better than 70.12% of 1225
companies
in the Biotechnology industry
Industry Median: 2.92
vs GNTA: 1.40
During the past 12 months, Genenta Science SPA's average Book Value Per Share Growth Rate was 36.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -18.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -9.40% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Genenta Science SPA was 16.90% per year. The lowest was -31.60% per year. And the median was -4.50% per year.
Back to Basics: PB Ratio
Genenta Science SPA (NAS:GNTA) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Genenta Science SPA PB Ratio Related Terms
Genenta Science SPA PB Ratio Historical Data
* Premium members only.
The historical data trend for Genenta Science SPA's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Genenta Science SPA's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genenta Science SPA PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Genenta Science SPA's PB Ratio distribution charts can be found below:
* The bar in red indicates where Genenta Science SPA's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Genenta Science SPA (GNTA) has a PB Ratio of 1.40 as of Jul. 08, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Genenta Science SPA and its competitors. According to the industry distribution chart, Genenta Science SPA ranks #366 out of 1225 companies in the Biotechnology industry, placing it in the top 29.9%.
Is Genenta Science SPA's PB Ratio too high?
Genenta Science SPA's current PB Ratio is 1.40. The Biotechnology industry median PB Ratio is 2.92. Genenta Science SPA's value of 1.40 is 52.1% below this industry median. Based on the distribution chart, Genenta Science SPA ranks #366 out of 1225 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Genenta Science SPA has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Genenta Science SPA's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Genenta Science SPA ranks #366 out of 1225 companies for PB Ratio. This puts Genenta Science SPA in the upper half of its industry. The industry median PB Ratio is 2.92. Genenta Science SPA's value of 1.40 is 52.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.92, based on 1,225 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genenta Science SPA's current PB Ratio of 1.40 is 52.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Genenta Science SPA and its competitors. For the Biotechnology industry, the median PB Ratio is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genenta Science SPA's current PB Ratio is 1.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genenta Science SPA stock overvalued right now?
Genenta Science SPA (GNTA) has a current PB Ratio of 1.40. The current PB Ratio is 1.40 and 52.1% below the Biotechnology industry median of 2.92. Genenta Science SPA's overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Genenta Science SPA (GNTA), the current PB Ratio is 1.40 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
31GF Score
Get the complete analysis for GNTA
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GNTA has been successfully added to your 
